摘要
目的观察依达拉奉联合高压氧治疗脑梗死的疗效。方法132例脑梗死随机分成2组,对照组65例采用依达拉奉治疗,30 mg,静脉滴注,2次/d,疗程14 d,观察组采用依达拉奉治疗的同时给予高压氧治疗,14 d后评定疗效。结果观察组和对照组的有效率分别是88.06%和72.31%,对照组与观察组比较P<0.05,差异有统计学意义。结论依达拉奉联合高压氧治疗脑梗死是一种更有效的治疗方法,值得推广。
Objective To evaluate the clinical efficacy of edaravone combined with hyperbaric oxygen in the treatment of cerebral infarction. Methods A total of 132 patients with cerebral infarction were randomly divided into two groups, i.e. trial group and control group, The control group （ n = 65 ） received edaravone （ 30 mg, ivgtt, bid） for 14 days, while the trial group （ n = 67 ） received additional hyperbaric oxygen treatment, Results Fourteen days after treatment, total effective rates in the trial and the control groups were 88.06% and 72.31% , respectively （ X^2 = 5.21, P 〈 0, 05 ）. There was significant difference between the two groups. Conclusion Edaravone plus hyperbaric oxygen is more effective in the treatment of cerebral infarction, and is worth spreading.
出处
《临床军医杂志》
CAS
2008年第1期43-45,共3页
Clinical Journal of Medical Officers
关键词
依达拉奉
高压氧
自由基清除剂
脑梗死
edaravone
hyperbaric oxygen
free radical scavenger
cerebral infarction
